NCT05394337 2026-05-05Neoadjuvant PD-1 Plus TIGIT Blockade in Patients With Cisplatin-Ineligible Operable High-Risk Urothelial CarcinomaM.D. Anderson Cancer CenterPhase 1/2 Recruiting10 enrolled